Molecular characterization of the circadian clock in patients with Parkinson's disease-CLOCK4PD Study protocol

• Published in: PloS one 2024-07, Vol.19 (7), p.e0305712
• Main Authors: Yalçin, Müge, Peralta, Ana Rita, Bentes, Carla, Silva, Cristiana, Guerreiro, Tiago, Ferreira, Joaquim J, Relógio, Angela
• Format: Article
• Language: English
• Subjects: Activity patterns; Adult; Aged; Analysis; Care and treatment; Case-Control Studies; Circadian Clocks - genetics; Circadian rhythm; Circadian Rhythm - genetics; Circadian rhythms; CLOCK Proteins - genetics; CLOCK Proteins - metabolism; Development and progression; Disease; Female; Gene expression; Genes; Genetic aspects; Health services; Humans; Male; Medical research; Medical treatment; Medicine, Experimental; Middle Aged; Movement disorders; Neurodegenerative diseases; Observational studies; Oscillations; Parkinson Disease - genetics; Parkinson Disease - physiopathology; Parkinson's disease; Patients; Phenotypes; Physiological effects; Physiology; Polysomnography; Questionnaires; Restless legs syndrome; Saliva; Saliva - metabolism; Sample size; Signs and symptoms; Sleep; Sleep apnea; Sleep disorders
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0305712

Circadian rhythms (CRs) orchestrate intrinsic 24-hour oscillations which synchronize an organism's physiology and behaviour with respect to daily cycles. CR disruptions have been linked to Parkinson's Disease (PD), the second most prevalent neurodegenerative disorder globally, and are associated to several PD-symptoms such as sleep disturbances. Studying molecular changes of CR offers a potential avenue for unravelling novel insights into the PD progression, symptoms, and can be further used for optimization of treatment strategies. Yet, a comprehensive characterization of the alterations at the molecular expression level for core-clock and clock-controlled genes in PD is still missing. The proposed study protocol will be used to characterize expression profiles of circadian genes obtained from saliva samples in PD patients and controls. For this purpose, 20 healthy controls and 70 PD patients will be recruited. Data from clinical assessment, questionnaires, actigraphy tracking and polysomnography will be collected and clinical evaluations will be repeated as a follow-up in one-year time. We plan to carry out sub-group analyses considering several clinical factors (e.g., biological sex, treatment dosages, or fluctuation of symptoms), and to correlate reflected changes in CR of measured genes with distinct PD phenotypes (diffuse malignant and mild/motor-predominant). Additionally, using NanoStringⓇ multiplex technology on a subset of samples, we aim to further explore potential CR alterations in hundreds of genes involved in neuropathology pathways. CLOCK4PD is a mono-centric, non-interventional observational study aiming at the molecular characterization of CR alterations in PD. We further plan to determine physiological modifications in sleep and activity patterns, and clinical factors correlating with the observed CR changes. Our study may provide valuable insights into the intricate interplay between CR and PD with a potential to be used as a predictor of circadian alterations reflecting distinct disease phenotypes, symptoms, and progression outcomes.